KRT19 and breast carcinoma: These data are consistent with a report from Max Wicha's group [9] on mouse mammary cells, which showed that CK19 might be a putative stem-cell marker and the findings of Peterson et al. [10] indicating CK19 as a marker of breast cancer progenitors.